Gazyva: Interim Phase III data

Interim data from 1,202 patients with previously untreated follicular lymphoma in the open-label, international Phase III GALLIUM trial showed that Gazyva plus chemotherapy followed by Gazyva

Read the full 264 word article

User Sign In